Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study

Psoriasis is commonly treated with topical corticosteroids, oral cytotoxic drugs and biologic agents, which can be associated with significant adverse effects (AEs), high cost and response attenuation. Additionally, patients often use alternative therapies ad hoc, which can be challenging to integra...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Exp Dermatol
Asıl Yazarlar: Alex, P., Williams, S., Sutton, L., Yesudas, T., Sutton, C., Thomas, S., Centola, M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2019
Konular:
Concise Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154690/
https://ncbi.nlm.nih.gov/pubmed/31419323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ced.14074
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller